from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3748/-

LFCtreatmentdescriptionclass of inhibitor

-0.253

Amikacinug/mL Amikacintranslation

-0.084

Cap5-10ug/mL Capreomycintranslation

-0.834

Rox10-50 ug/mL Roxithromycintranslation

0.231

SM2-5 ug/mL Streptomycintranslation

-1.424

Tet5-10 ug/mL Tetracyclinetranslation

0.412

Rif0.2-5ug/mL Rifampicintranscription

-1.088

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.342

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.609

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.513

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.506

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.622

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.912

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.715

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.736

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.038

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.131

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.021

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.022

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.314

KCN5-20 ug/mL Potassium cyaniderespiration

0.304

NaN30.2-2 mM Sodium aziderespiration

0.593

Nigericin50 uM Nigericinrespiration

-0.272

TRC10-150 ug/mL Triclosanrespiration

0.039

TRZ10-25 ug/mL Thioridazinerespiration

-2.424

Valinomycin0.5-10 uM Valinomycinrespiration

0.635

ZnSO42 mM ZnSO4respiration

0.403

menadione6-10 ug/mL Menadionerespiration

-0.522

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.105

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.194

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.281

NRP_1Non-replicating persistence stage 1dosRassociated

0.233

Amp0.2mg/mL AmpicillincellWall

0.085

Cephalexin20-100 ug/mL CephalexincellWall

-0.116

Cerulenin0.32-5 ug/mL CerulenincellWall

0.327

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.624

EMB10-20 ug/mL EthambutolcellWall

0.199

Eta12-40 ug/mL EthionamidecellWall

0.457

INH0.2-0.4 ug/mL IsoniazidcellWall

0.168

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.502

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.970

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.877

BZA0.12 mg/mL BenzamidearomaticAmides

0.725

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.378

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.424

H2O24 mM hydrogen peroxideDNAdamaging

-0.596

Levo10 ug/mL LevofloxacinDNAdamaging

0.311

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.078

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.630

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.224

UVUV-irradiationDNAdamaging

0.133

ARP41-4 ug/mL Antitubercular compound ARP4?

0.215

Antimycin12.5-50 ug/mL Antimycin A?

0.097

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.897

PA_110-50 ug/mL Antitubercular compound PA-1?

0.874

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.897

PA8240.2-2 ug/mL PA-824?

-0.576

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.562

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.357

Verapamil50 uM Verapamil?

0.605

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.418

methoxatin10-20 ug/mL Methoxatin?